For people who have been prescribed Wegovy, learning how to use the injection pen correctly can make treatment feel much less intimidating. The good news is that Wegovy is designed for once-weekly use, and the injection itself takes only a few moments once you become familiar with the process. Still, careful preparation and proper technique matter, particularly when you are using the medication for the first time. This guide explains what Wegovy is, what it is prescribed for, and how to inject Wegovy safely and confidently with the help of simple step-by-step instructions.
A Safety Note:
Because individual treatment plans can differ, always follow the instructions provided by your healthcare professional and the Instructions for Use that come with your particular Wegovy device.
Wegovy is a prescription medicine containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by acting on GLP-1 receptors in the body, helping regulate appetite and food intake. Wegovy is used alongside a reduced-calorie diet and increased physical activity as part of a broader approach to weight management and, for certain patients, cardiovascular risk reduction.
The injectable form of Wegovy does not come in only one format, and knowing which one you were dispensed matters before you inject. Most patients receive a prefilled, single-dose pen that already holds one preset dose, with the needle hidden inside, so nothing has to be measured or attached. Wegovy is also supplied as a single-dose prefilled syringe with an integrated needle, and as the Wegovy FlexTouch single-patient-use pen, which contains four 2.4 mg doses and takes a new needle for every injection. Whichever device you have, the injection is given subcutaneously, meaning the medicine is delivered into the tissue beneath the skin rather than into a muscle or vein. Semaglutide is also available under the Wegovy name as a daily tablet, which is not injected at all.
| Device | Doses per device | Needle | Storage |
|---|---|---|---|
| Prefilled single-dose pen | 1 preset dose | Built in and hidden inside the pen | 2°C to 8°C; may be kept at 8°C to 30°C for up to 28 days before the cap is removed; discard after use |
| Single-dose prefilled syringe | 1 preset dose | Integrated | Same as the single-dose pen; discard after use |
| Wegovy FlexTouch single-patient-use pen | 4 doses of 2.4 mg | New needle attached and discarded for every injection | Refrigerated before first use; after first use, 56 days at 15°C to 30°C or in the refrigerator |
The step-by-step instructions further down describe the single-dose pen, which is the presentation most patients start on. If you were given a FlexTouch pen or a prefilled syringe, the preparation and disposal steps differ, and the Instructions for Use packaged with your medicine take priority over any general guide.
“Always remove and safely discard the needle after each injection. Store the WEGOVY FlexTouch single-patient-use pen without an injection needle attached. Always use a new needle for each injection.” — U.S. Food and Drug Administration, WEGOVY Prescribing Information, Section 16
It is also worth mentioning that Wegovy should be taken exactly as prescribed. The usual injectable treatment begins with a lower dose, which is gradually increased at intervals determined by the prescribing healthcare professional. This gradual dose escalation is intended to help the body adjust to treatment and reduce the likelihood of gastrointestinal side effects.
A Safety Note:
The prescription of Wegovy (as well as the development of its dose escalation schedule) is a prerogative of a licensed healthcare professional’s expertise. A patient should follow the product’s administration instructions carefully to avoid any complications (such as an allergic reaction or skin irritation).
Wegovy has several FDA-approved indications for its injectable formulation. It may be prescribed as an addition to diet and increased physical activity to help reduce excess body weight and maintain weight reduction over the long term in adults with obesity, as well as in adults with overweight who have at least one weight-related medical condition. It can also be prescribed for adolescents aged 12 and older with obesity.
Another important indication concerns cardiovascular health. In adults with established cardiovascular disease who also have obesity or overweight, Wegovy can be used to reduce the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.
The FDA also approved Wegovy for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis, commonly known as MASH, in adults with moderate to advanced liver fibrosis corresponding to stages F2 to F3. This indication was approved under the accelerated approval pathway and therefore has specific conditions surrounding confirmation of clinical benefit.
It is important to remember that Wegovy is a prescription medicine, not a general-purpose weight-loss product. A healthcare professional should determine whether it is appropriate based on a patient’s medical history, current medications, health conditions, and treatment goals. Wegovy should also not be combined with other semaglutide-containing products or another GLP-1 receptor agonist unless specifically directed by a healthcare professional. If you are weighing it against other weight-management medications, that comparison belongs in the consultation rather than in the pharmacy queue.
The first injection is often the one that generates the most questions. Taking a few minutes to prepare can make the process considerably easier. If your doctor, nurse, or pharmacist has demonstrated the technique to you, use their instructions as your primary guide. Before every injection, gather everything you need in one place. You will generally need your Wegovy pen, an alcohol swab or soap and water for cleaning the injection area, gauze or a cotton ball, and an FDA-cleared sharps disposal container for disposing of the used pen. Wash your hands thoroughly before handling the medication.
Next, inspect your pen carefully. Confirm that you have the correct medication and prescribed dose, and check the expiration date. The medicine visible through the pen window should be clear and colorless. Do not use the pen if it appears to have been used already, if it is damaged, if the medicine is not clear and colorless, or if the expiration date has passed. If anything about the pen looks unusual, do not try to repair it or inject the medication simply because you are unsure. Instead, contact your healthcare professional or the appropriate pharmacy for guidance.
A Side Note:
If you are not comfortable giving yourself the injection, ask a friend or family member who is trained to use the Wegovy pen for some help.
A subcutaneous injection of Wegovy is administered under the skin in one of three general areas: the abdomen (lower stomach), upper leg (thigh), or upper arm. The choice depends largely on the personal preference of the patient. If you inject into the abdomen, the manufacturer’s instructions recommend staying at least two inches away from the belly button. Your healthcare professional can help you decide which site is most convenient and appropriate for you. Although you can continue using the same general area from week to week, avoid injecting into exactly the same spot each time. Rotating injection spots can help prevent repeated irritation of one small area of skin. You should also avoid skin that is tender, bruised, red, hard, scarred, or affected by stretch marks. Once you have chosen a suitable site, clean it with an alcohol swab or soap and water and allow the skin to dry. Try not to touch the cleaned area before the injection.
A Safety Note:
It is important not to use a Wegovy pen if it appears broken. Although small air bubbles are normal, make sure that the medication is clear and colorless before injecting it.
Once your supplies (Wegovy pen, alcohol swab, gauze pad or cotton ball, and sharps disposal container) are ready and you have selected an appropriate injection site, the actual injection is straightforward. The following overview is based on the manufacturer’s Instructions for Use for the Wegovy single-dose pen, but patients should always review the specific Instructions for Use supplied with their own medication. The technique is close to the one used for other once-weekly semaglutide pens, though the devices are not interchangeable.
A Side Note:
To make the Wegovy injection more comfortable, one might consider taking the pen out of the refrigerator shortly before use. The prescribing information allows an unopened pen to be kept at 8°C to 30°C for up to 28 days, so a short time out of the fridge does not compromise the medicine, but semaglutide should not be allowed to get warm beyond what the storage instructions permit.
Hold the pen as instructed and pull the pen cap straight off. The needle is hidden inside the pen, so you do not need to handle or manipulate it. Be careful not to press the needle cover against anything before the injection because doing so can cause an accidental needlestick.
Place the pen firmly against the cleaned injection site. Make sure you can see the pen window clearly and that you are using the injection site recommended by your healthcare professional.
Press the pen firmly against your skin. The injection begins when the yellow bar starts moving. If it does not appear to move, the pen may need to be pressed more firmly against the skin.
Continue to press firmly while the medicine is being delivered. You may hear two clicks during the process, but hearing the clicks does not mean you should immediately remove the pen: the first click signals that the injection has started, and the second that it is still ongoing. The Instructions for Use do not set a fixed number of seconds for the injection. What matters is the yellow bar, because the dose is finished only when it has stopped moving, and lifting the pen before then can leave medicine on the skin so that you do not receive the full dose.
“Push the pen firmly against your skin and keep applying pressure until the yellow bar has stopped moving. If the yellow bar does not start moving, press the pen more firmly against your skin.” — U.S. Food and Drug Administration, WEGOVY Instructions for Use (single-dose pen)
Once the yellow bar has stopped moving and the injection is complete, slowly lift and remove the pen from your skin according to the manufacturer’s instructions. If a small amount of blood appears, you can gently press the area with gauze or a cotton ball. Avoid rubbing the site.
Wegovy single-dose pens and prefilled syringes are single-use devices and should not be reused. Dispose of the used pen into an FDA-cleared sharps disposal container rather than placing it loose into household trash. If you were dispensed the FlexTouch pen instead, the pen itself is kept for its four weekly doses, but the needle must be removed and dropped into the sharps container after every injection, and the pen must be stored without a needle attached.
A Safety Note:
The entire injection process may feel unfamiliar at first, but most people find that it quickly becomes a simple part of their weekly routine. If you are uncertain about whether you administered the complete dose, do not automatically take another dose. Contact your healthcare professional or pharmacist for advice.
Within one week, injectable Wegovy should generally be administered only once (weekly injections on the same day each week, possibly into the same body area but not in the exact same spot). You can take the injection at any time of day, and it can be taken with or without food. The prescribing information states plainly that the injection site and the time of day can be changed without requiring a dose adjustment. Consistency can make weekly treatment easier to remember. Some patients choose a particular day that fits naturally into their routine, such as a day when they are usually at home. Your chosen schedule should always follow the instructions given by your healthcare professional.
Wegovy treatment usually begins at 0.25 mg once weekly for the first four weeks, and the dose is then increased roughly every four weeks until the appropriate maintenance dose is reached. The prescribing information sets out the escalation schedule below for all approved indications in adults and in patients aged 12 and older.
| Stage | Weeks | Once-weekly dose |
|---|---|---|
| Starting dosage | 1 through 4 | 0.25 mg |
| Dose escalation | 5 through 8 | 0.5 mg |
| Dose escalation | 9 through 12 | 1 mg |
| Dose escalation | 13 through 16 | 1.7 mg |
| Maintenance | 17 and onward | 2.4 mg (recommended) or 1.7 mg |
For weight reduction in adults, the label adds one further step: in patients who have tolerated 2.4 mg for at least four weeks and for whom additional weight reduction is clinically indicated, the dose may be increased to a maximum of 7.2 mg once weekly. If a dose is not tolerated during escalation, the label allows the next increase to be delayed by four weeks. The correct dose for you is the one prescribed by your healthcare professional. Do not increase your dose more quickly simply because you feel that a higher dose might produce faster results.
Missing a weekly injection can happen, particularly when treatment is still becoming part of your routine. The appropriate response depends on how much time has passed and when your next scheduled dose is due. The prescribing information states that if the next planned dose is more than two days (48 hours) away, the missed dose can be taken as soon as possible. If the next scheduled dose is less than two days away, the missed dose should be skipped and the next dose taken on the regular day.
Two or more missed doses in a row are treated differently. In that situation the label directs that dose escalation be restarted at a lower dosage, in order to reduce the risk of gastrointestinal side effects, rather than simply resuming at the dose you were on. That decision belongs to your healthcare professional, so speak with them about how to restart treatment instead of making your own dosing decision.
Wegovy is not suitable for everyone. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma, or MTC, and in people with Multiple Endocrine Neoplasia syndrome type 2, also known as MEN 2. It should also not be used by anyone with a known hypersensitivity to semaglutide or one of its ingredients.
Patients should discuss their complete medical history and current medications with their healthcare professional before beginning treatment. In people with type 2 diabetes, blood glucose should be monitored before starting Wegovy and during treatment. The risk of hypoglycemia can also increase when Wegovy is used together with insulin or certain insulin secretagogues.
Wegovy is associated with gastrointestinal side effects, and more serious reactions can occur. The prescribing information includes warnings concerning pancreatitis, gallbladder disease, acute kidney injury associated with volume depletion, and severe gastrointestinal adverse reactions. If you develop symptoms that concern you, contact your healthcare professional promptly rather than attempting to manage a potentially serious reaction on your own.
It is equally important to tell your healthcare team that you use Wegovy before undergoing anesthesia or deep sedation. Your medical team can determine what precautions are appropriate for your circumstances.
Once you have mastered the technique, the biggest challenge may simply be remembering the injection day. Building the medication into an established weekly routine can help. You might keep the injection day associated with another regular activity, while making sure the medication is stored according to its specific storage instructions.
It can also be helpful to keep a simple record of your injection dates and prescribed doses. This can make it easier to notice if you have missed an injection and gives your healthcare professional useful information during follow-up appointments.
Most importantly, do not hesitate to ask for another demonstration if you are uncomfortable with the injection technique. A healthcare professional can watch you perform the process and correct small mistakes before they become habits. The FDA prescribing information specifically directs that patients and caregivers be trained on proper injection technique for their prescribed presentation before treatment starts, and that they be trained again if the presentation changes.
To sum it all up, learning how to inject Wegovy does not have to be complicated. With the correct pen, a suitable injection site, careful preparation, and a consistent once-weekly routine, the process can quickly become a manageable part of your treatment plan. Always use Wegovy exactly as prescribed and consult your healthcare professional whenever you have questions about dosing, missed injections, side effects, or whether the medication remains appropriate for you.
Patients with a valid prescription from their doctor are eligible to order Wegovy, along with a wide selection of other diabetes-related medications, through InsulinStore. By combining a valid prescription with appropriate medical guidance, patients can make medication access a more convenient part of their ongoing healthcare routine.
Yes. The prescribing information states that Wegovy is injected once weekly at any time of day, with or without food, and that both the time of day and the injection site can be changed without a dose adjustment. What should stay consistent is the day of the week.
It is not required. Wegovy is stored in the refrigerator, and an unopened pen may also be kept at 8°C to 30°C for up to 28 days before the cap is removed. Some patients find a pen that has been out of the fridge for a short time more comfortable to inject, but the medicine works the same either way.
Press the pen more firmly against your skin. If the yellow bar still does not move, or if it stops part-way through the injection, do not take a second dose. The Instructions for Use direct patients to contact their healthcare provider or the manufacturer in that situation.
No. A single-dose pen or prefilled syringe is discarded straight after one injection. The FlexTouch pen is kept for its four doses, but its needle is removed and discarded after every single injection, and the pen is stored without a needle attached.
Into an FDA-cleared sharps disposal container, never loose in household trash. If you do not have one, the FDA describes suitable heavy-duty alternatives and state-by-state disposal rules on its sharps disposal page.
U.S. Food and Drug Administration. (2026). WEGOVY (semaglutide) injection, for subcutaneous use; WEGOVY (semaglutide) tablets, for oral use: Full Prescribing Information. Silver Spring, MD: Center for Drug Evaluation and Research. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Novo Nordisk. (2026). WEGOVY Instructions for Use: Prefilled Single-Dose Pen. In WEGOVY Prescribing Information. Silver Spring, MD: U.S. Food and Drug Administration. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
U.S. Food and Drug Administration. (2024). Safely Using Sharps (Needles and Syringes) at Home, at Work and on Travel. Silver Spring, MD: Center for Devices and Radiological Health. https://www.fda.gov/medical-devices/consumer-products/safely-using-sharps-needles-and-syringes-home-work-and-travel
Get a 5% discount for the 1st order after registration
Create Account